title: Targeting regulatory T cells in cytokine-induced killer cell cultures (Review).
abstract: Regulatory T cells (Tregs) are potent immunosuppressive cells that promote tumor growth and invasion by inducing immune escape and suppressing the antitumor immune response. Cytokine-induced killer (CIK) cells are considered to be the primary candidate for adoptive immunotherapy due to their strong antitumor activity. It was recently reported that the concomitant presence of Tregs may decrease the cytotoxicity of CIK cells. Therefore, depletion or downregulation of Tregs in CIK cell cultures by optimizing the culture program may enhance CIK cell cytotoxicityin vitroandin vivo. The aim of the present review was to summarize the currently available studies on the optimal culture strategy for improving the antitumor activity of CIK cells through targeting Tregs.
authors.affiliation: Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
authors.forename: Qianshan
authors.initials: Q
authors.lastname: Tao
authors.affiliation: Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
authors.forename: Huiping
authors.initials: H
authors.lastname: Wang
authors.affiliation: Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
authors.forename: Zhimin
authors.initials: Z
authors.lastname: Zhai
keywords: adoptive immunotherapy; cytokine-induced killer cells; regulatory T cells
references.citation: Blood. 2011 Sep 22;118(12):3301-10
references.pmid: 21821703
references.citation: J Immunother. 2012 May;35(4):337-43
references.pmid: 22495391
references.citation: J Immunol. 2007 Feb 15;178(4):2018-27
references.pmid: 17277105
references.citation: Immunol Cell Biol. 2013 May;91(5):340-9
references.pmid: 23567897
references.citation: Trends Immunol. 2012 Dec;33(12):626-32
references.pmid: 22951308
references.citation: J Immunol. 2012 Dec 15;189(12):5649-58
references.pmid: 23129754
references.citation: J Immunother. 2013 Nov-Dec;36(9):462-7
references.pmid: 24145357
references.citation: Cytotherapy. 2012 Jan;14(1):91-103
references.pmid: 21973023
references.citation: Leuk Res. 2011 Sep;35(9):1136-42
references.pmid: 21652069
references.citation: J Clin Immunol. 2007 May;27(3):317-26
references.pmid: 17468835
references.citation: Bone Marrow Transplant. 2006 Nov;38(9):621-7
references.pmid: 16980990
references.citation: Front Immunol. 2013 Jun 19;4:155
references.pmid: 23801992
references.citation: Cancer Immunol Immunother. 2004 Nov;53(11):1018-26
references.pmid: 15185013
references.citation: N Engl J Med. 2011 Dec 1;365(22):2129-31
references.pmid: 22129258
references.citation: Gene Ther. 1998 Jan;5(1):31-9
references.pmid: 9536262
references.citation: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2001 Mar;9(1):48-51
references.pmid: 12578645
references.citation: Int Immunol. 2008 Jul;20(7):841-8
references.pmid: 18469328
references.citation: J Immunother. 2005 Mar-Apr;28(2):120-8
references.pmid: 15725955
references.citation: J Transl Med. 2013 Mar 28;11:83
references.pmid: 23536996
references.citation: Cytotherapy. 2012 Apr;14(4):483-93
references.pmid: 22277010
references.citation: Adv Cancer Res. 2010;107:57-117
references.pmid: 20399961
references.citation: Cancer Biol Ther. 2012 Jun;13(8):623-9
references.pmid: 22555808
references.citation: J Immunol. 2013 Feb 15;190(4):1416-23
references.pmid: 23325887
references.citation: J Transl Med. 2010 Dec 07;8:129
references.pmid: 21138560
references.citation: J Exp Med. 1991 Jul 1;174(1):139-49
references.pmid: 1711560
references.citation: Sci Transl Med. 2013 Apr 3;5(179):179ra43
references.pmid: 23552371
references.citation: Nat Immunol. 2007 Dec;8(12):1353-62
references.pmid: 17982458
references.citation: Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):823-8
references.pmid: 23384903
references.citation: Nat Rev Immunol. 2006 Apr;6(4):295-307
references.pmid: 16557261
references.citation: Int J Cancer. 2010 Aug 15;127(4):759-67
references.pmid: 20518016
references.citation: J Cancer Res Clin Oncol. 2011 Feb;137(2):305-10
references.pmid: 20407789
references.citation: Front Oncol. 2012 Apr 09;2:32
references.pmid: 22655268
references.citation: J Clin Oncol. 2003 Aug 15;21(16):3127-32
references.pmid: 12915604
references.citation: Iran J Pediatr. 2012 Mar;22(1):43-51
references.pmid: 23056858
references.citation: Zhonghua Yi Xue Za Zhi. 2005 Nov 23;85(44):3134-8
references.pmid: 16405818